Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of Induction

Introduction: High-strength mesalazine formulations play an important role in providing a convenient option to increase the dose in ulcerative colitis (UC) patients and therefore avoiding the switch to another therapeutic class. Higher doses of mesalazine may be required during periods of remission...

Descripció completa

Dades bibliogràfiques

Autors principals:	Geert D'Haens, Ekaterina Safroneeva, Helen Thorne, Raphaël Laoun
Format:	Artigo
Idioma:	Inglês
Publicat:	Karger Publishers 2023-06-01
Col·lecció:	Inflammatory Intestinal Diseases
Matèries:	ulcerative colitis mesalazine disease extent maintenance high dose faecal calprotectin mayo endoscopic subscore
Accés en línia:	https://beta.karger.com/Article/FullText/531372
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!